Original paper
Outcomes of systemic targeted therapy in recurrent renal cell carcinoma treated with adjuvant sunitinib
Volume: 128, Issue: 2, Pages: 254 - 261
Published: Apr 19, 2021
Abstract
Objective To assess the efficacy and tolerability of rechallenge with sunitinib and other targeted therapies (TTs) in patitents with relapsed recurrent renal cell carcinoma (RCC) in the advanced setting. Methods In this multi‐institutional retrospective study, patients with relapsed RCC were rechallenged with sunitinib or other systemic TTs as a first‐line therapeutic approach after failed adjuvant sunitinib treatment. Patient characteristics,...
Paper Details
Title
Outcomes of systemic targeted therapy in recurrent renal cell carcinoma treated with adjuvant sunitinib
Published Date
Apr 19, 2021
Volume
128
Issue
2
Pages
254 - 261
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History